CFI-402411 clinical trials

Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies

This study is testing a new drug called CFI-402411, by itself and with another drug called pembrolizumab, for advanced cancers. Doctors want to see if these treatments are safe and if they can help patients whose previous treatments haven't worked.